Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

AEMD
AETHLON MEDICAL INC
stock NASDAQ

At Close
Jul 17, 2026 2:16:31 PM EDT
0.6700USD-0.030%(-0.0002)77,809
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Jul 15, 2026 8:50:30 AM EDT
0.7100USD+5.954%(+0.0399)0
After-hours
Jul 17, 2026 4:19:30 PM EDT
0.6400USD-4.463%(-0.0300)2,902
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
08:02AM EST  Aethlon Medical to Release Third Quarter Financial Results and Host Conference   PR Newswire
Nov 17, 2021
06:22AM EST  AEMD: Strong balance sheet, expanded management team & new CRO relationship expected to facilitate clinical efforts   Benzinga
Nov 12, 2021
01:11PM EST  Watching Aethlon Medical Shares; Zacks Sets $8 Price Target   Benzinga
Nov 9, 2021
06:29PM EST  Aethlon Medical Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $131.97K Miss $190.00K Estimate   Benzinga
04:16PM EST  Aethlon Medical Announces Second Quarter Financial Results and Provides   PR Newswire
12:08PM EST  Aethlon Medical's Return On Capital Employed Insights   Benzinga
11:42AM EST  The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Nov 2, 2021
08:04AM EDT  Aethlon Medical to Release Second Quarter Financial Results and Host Conference   PR Newswire
Oct 21, 2021
12:12PM EDT  Aethlon Medical Granted Worldwide Patent Titled 'DEVICES AND METHODS FOR TREATING A CORONAVIRUS INFECTION AND SYMPTOMS THEREOF'   Benzinga
Oct 12, 2021
08:11AM EDT  Aethlon Announces Publication Of Two Case Studies Of Critically Ill COVID-19 Patients Treated With Hemopurifier   RTTNews
08:03AM EDT  Aethlon Medical Reports Peer-Reviewed Publication Of 2 Case Studies Of Critically-Ill COVID-19 Patients Treated With Its Hemopurifier   Benzinga
08:03AM EDT  Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of   PR Newswire
Sep 30, 2021
08:18AM EDT  Aethlon Medical Announces Contracting With PPD To Advance Hemopurifier Clinical Programs   Benzinga
08:03AM EDT  Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical   PR Newswire
Sep 22, 2021
10:34AM EDT  Mid-Morning Market Update: Markets Open Higher; General Mills Reports Upbeat Q1 Results   Benzinga
Sep 17, 2021
10:39AM EDT  How Good Are Aethlon Medical's Earnings? | Return On Capital Employed   Benzinga
Sep 9, 2021
05:35AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.25 A.M. EDT).   RTTNews
Sep 7, 2021
08:03AM EDT  Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment   PR Newswire
Aug 16, 2021
12:11PM EDT  AEMD: Strong Cash Position to Advance the Hemopurifier; Clinical Trials Move Forward   Benzinga
Aug 9, 2021
05:35PM EDT  Aethlon Medical Q1 EPS $(0.16) Misses $(0.13) Estimate, Government Contract Revenue $132K   Benzinga
04:15PM EDT  Aethlon Medical Announces First Quarter Financial Results and Provides   PR Newswire
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 29, 2021
01:33PM EDT  Aethlon Medical to Release First Quarter Financial Results and Host Conference   PR Newswire
Jul 19, 2021
11:50AM EDT  Looking into Aethlon Medical's Return on Capital Employed   Benzinga
10:15AM EDT  Shares of Aethlon Medical Inc. (AEMD) is currently trading at $4.15, up 39 cents or 10.61%, with trading volume rising over 3.80 million versus an average volume of 5.54 million shares. The stock has been trading in the range of $1.22 - $12.49 for the past one year.   RTTNews
Jul 13, 2021
10:05AM EDT  Looking Into Aethlon Medical's Return On Capital Employed   Benzinga
Jul 6, 2021
01:51PM EDT  Aethlon Medical Insights: Return On Capital Employed   Benzinga
Jul 1, 2021
02:21PM EDT  AEMD: Stronger Cash Position Enhances AEMD's Goal to Advance the Hemopurifier   Benzinga
Jun 25, 2021
06:58AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
06:12AM EDT  HC Wainwright & Co. Maintains Buy on Aethlon Medical, Raises Price Target to $9   Benzinga
Jun 24, 2021
04:19PM EDT  Aethlon Medical Reports FY21 EPS $(0.65) Down From $(1.87) YoY, Sales $659K Up From $650K   Benzinga
04:16PM EDT  Aethlon Medical Announces Fiscal Year End Financial Results and Provides   PR Newswire
08:12AM EDT  The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO   Benzinga
04:10AM EDT  Earnings Scheduled For June 24, 2021   Benzinga
Jun 21, 2021
03:28PM EDT  Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference   PR Newswire
Jun 13, 2021
12:31PM EDT  AEMD: First Ever In Vivo Removal of COVID Virus From Bloodstream of An Infected Patient   Benzinga
Jun 10, 2021
02:30PM EDT  Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Materialise Shares Slide   Benzinga
12:08PM EDT  Mid-Day Market Update: Yiren Digital Rises Following Q1 Results; Ocugen Shares Slide   Benzinga
10:17AM EDT  Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Increases to 5%   Benzinga
09:37AM EDT  Aethlon Medical Reports $12.425 Mln Registered Direct Offering Priced At-the-Market Under Nasdaq Rules   RTTNews
09:11AM EDT  Aethlon Medical Reports 1.38M Share Offering At $9/Share   Benzinga
09:11AM EDT  Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced   PR Newswire
08:57AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Jun 10, 2021: ORCL, AEMD, SRNG, BFLY, CLNE   Benzinga
08:13AM EDT  The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal   Benzinga
Jun 9, 2021
02:50PM EDT  Mid-Afternoon Market Update: Dow Drops Over 50 Points; Comtech Telecommunications Shares Plunge   Benzinga
12:24PM EDT  Mid-Day Market Update: United Natural Foods Falls On Sales Miss; Aethlon Medical Shares Jump   Benzinga
10:13AM EDT  Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Misses Views   Benzinga
05:25AM EDT  Aethlon Medical Shares Rise 500% in Premarket Trading on Wednesday, Following Posting of Zacks SCR Article Tuesday 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient'   Benzinga
Jun 3, 2021
09:11AM EDT  Aethlon Medical Unveils Publication Of Case Studies Of 2 Critically Ill COVID-19 Patients Treated With Hemopurifier   RTTNews
08:03AM EDT  Aethlon Medical Highlights Publication Of Case Studies Of Two Critically Ill COVID-19 Patients Treated With Hemopurifier   Benzinga
08:02AM EDT  Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients   PR Newswire
Jun 1, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021   Benzinga
08:50AM EDT  HC Wainwright & Co. Initiates Coverage On Aethlon Medical with Buy Rating, Announces Price Target of $5   Benzinga
May 30, 2021
10:45AM EDT  AEMD: Added Liquidity to Advance Hemopurifier   Benzinga
Mar 1, 2021
08:03AM EST  Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences   PR Newswire
Feb 11, 2021
12:04PM EST  Aethlon Medical Shares Resume Trade, Pullback From Session High; Stock Down 9% For Session   Benzinga
Feb 10, 2021
05:01PM EST  Aethlon Medical Q3 EPS $(0.20) Misses $(0.16) Estimate, Sales $624.87K Up From $413.46K YoY   Benzinga
05:00PM EST  CORRECTION: Aethlon Medical Reported Q3 Sales Of $624.87K Up From $413.46K; Earlier Headline Said Sales Of $624.87M   Benzinga
04:30PM EST  Aethlon Medical Q3 EPS $(0.20) Misses $(0.16) Estimate, Sales $624.87M Up From $413.46K YoY   Benzinga
04:15PM EST  Aethlon Medical Announces Third Quarter Financial Results and Provides   PR Newswire
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
03:43AM EST  Earnings Scheduled For February 10, 2021   Benzinga
Feb 6, 2021
12:42PM EST  The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight   Benzinga
Feb 4, 2021
08:03AM EST  Aethlon Medical to Release Third Quarter Financial Results and Host Conference   PR Newswire
Jan 8, 2021
12:15PM EST  Maxim Group Initiates Coverage On Aethlon Medical with Buy Rating, Announces Price Target of $6   Benzinga
Jan 6, 2021
08:07AM EST  Aethlon Medical Appoints Steven LaRosa, M.D. As Chief Medical Officer   Benzinga
08:03AM EST  Aethlon Medical Expands Leadership Team with Appointment of Chief Business   PR Newswire
Jan 4, 2021
08:03AM EST  Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference   PR Newswire
Dec 21, 2020
10:51AM EST  IPOs Drive Day Trading Profits In The Final Weeks Of 2020   Benzinga
Dec 16, 2020
10:36AM EST  Shares of nano-cap company Aethlon Medical, Inc. (AEMD) jumped 45% on Wednesday morning after the company announced that first patient was treated in first-in-human clinical trial of Hemopurifier in head and neck cancer.   RTTNews
08:11AM EST  Aethlon Says First Patient Treated In First-in-Human Clinical Trial Of HEMOPURIFIER In Head And Neck Cancer   RTTNews
08:07AM EST  Aethlon Medical Announces First Patient Treated In First-In-Human Clinical Trial Of HEMOPURIFIER In Head And Neck Cancer   Benzinga
08:04AM EST  Aethlon Medical Announces First Patient Treated in First-in-Human Clinical   PR Newswire
Nov 3, 2020
08:07AM EST  Aethlon Names Charles Fisher CEO, Effective As Of October 30   RTTNews
08:02AM EST  Aethlon Announces Appointment Of Charles Fisher As CEO   Benzinga
08:02AM EST  Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief   PR Newswire
Oct 28, 2020
04:54PM EDT  Aethlon Medical Q2 EPS $(0.15) Up From $(1.29) YoY   Benzinga
04:16PM EDT  Aethlon Medical Announces Second Quarter Financial Results and Provides   PR Newswire
Oct 19, 2020
08:02AM EDT  Aethlon Medical To Release Second Quarter Financial Results and Host Conference   PR Newswire
Sep 9, 2020
08:02AM EDT  Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment   PR Newswire
Aug 27, 2020
08:02AM EDT  Aethlon Medical to Present at the LD Micro 500 Virtual Conference   PR Newswire
Aug 11, 2020
04:25PM EDT  Aethlon Medical Q1 EPS $(0.15) Down From $(0.11) YoY   Benzinga
04:15PM EDT  Aethlon Medical Announces First Quarter Financial Results and Provides   PR Newswire
04:02AM EDT  Earnings Scheduled For August 11, 2020   Benzinga
Aug 6, 2020
08:06AM EDT  Aethlon Medical Reports Collaboration With University Of Pittsburgh On National Institutes For Health Grant For Head And Neck Cancer, Award Valued At $3.5M Over 5 Years   Benzinga
08:01AM EDT  Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH   PR Newswire
Aug 4, 2020
12:19PM EDT  Aethlon Medical To Release First Quarter Financial Results and Host Conference   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC